On May 9, 2024, Eli Lilly and Company announced that it held its annual general meeting of shareholders on May 6, 2024, and declared voting results. Accordingly, a shareholder proposal from Trinity Health, requesting to establish and report on a process by which the impact of extended patent exclusivities on product access would be considered in deciding whether to apply for secondary and tertiary patents was not approved.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
878.4 USD | -0.55% | +3.35% | +50.70% |
Jun. 14 | Health Care Slips as Gilead Rallies on Weight-Loss Plans - Health Care Roundup | DJ |
Jun. 14 | Investors need more time to assess Fed comments |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Declaration of Voting Results by Eli Lilly and Company